McKesson Corporation (MCK) earnings on August 5, 2026
More McKesson Corporation earnings
Prior outlook: No statistical edge
McKesson's stock swung wildly after its latest financial results, climbing as much as 4% before settling 0.6% lower. Even with analysts raising their price targets, the shares ended the day down.
MCK price around the earnings
871.38
Change: -0.8%
2026-08-06, 20:00 UTC
- Price: green if it ends above the starting price; red if it ends below
- Start of the measured window
- End of the measured window
- Market open
- No trading (market closed)
- Starting price
Prior thesis
Prior outlook: No statistical edge
- Thesis published
- Results released
Strong earnings history and analyst upgrades support an optimistic thesis, but sharply declining trajectory and crowded retail positioning create sell-the-news risk.
Context analyzed before publication
- Trend
- Sharp decline from 91.4 to 39.4 over 5 days contexts sell-the-news risk materialization despite strong earnings history.
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 1.53
- Analysts covering the stock
- 15
- Average price target
- 947.13
- Lowest price target
- 812
- Highest price target
- 1,065
- Upside to price target
- 9.5%
- Quarterly earnings growth
- 33.5%
- Revenue growth
- 6%
- Forward EPS
- 50.38
- Trailing EPS
- 37.06
- Analyst moves in the last 60 days
- 3
- Strong buy: 3
- Buy: 11
- Hold: 3
- Sell: 0
- Strong sell: 0
- Strong buy
- 3
- Buy
- 11
- Hold
- 3
- Sell
- 0
- Strong sell
- 0
- July 24, 2026 · Citigroup: Maintains rating (Buy → Buy)
- July 21, 2026 · TD Cowen: Maintains rating (Buy → Buy)
- June 10, 2026 · Barclays: Maintains rating (Overweight → Overweight)
News and sentiment
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- High
- Normalized volume
- 99%
News
Sources (4)
- Citigroup Maintains Buy on McKesson, Raises Price Target to $1000 (opens in a new tab) — Benzinga
- McKesson Raises Quarterly Dividend From $0.82 To $0.94 Per Share (opens in a new tab) — Benzinga
- TD Cowen Maintains Buy on McKesson, Lowers Price Target to $989 (opens in a new tab) — Benzinga
- Congressional Trading Report: Rep. Ritchie Torres Bought Over $1K In McKesson Stock (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 830.87
- Average true range (ATR)
- 2.8%
- Distance to 52-week high
- -13.1%
- 14-day change (14d)
- +0.2%
- 30-day change (33d)
- +5.7%
- 30-day relative strength
- +2.1%
- SPY change (33d)
- +3.5%
- Nearest support
- 825.98
- Distance to nearest support
- 0.6%
- Nearest resistance
- 834.51
- Distance to nearest resistance
- 0.4%
- Volume accumulation ratio (14d / 46d)
- 0.84
- Mid: 825.98 (0.6% away, 0.21 ATR, 19 touches)
- Major: 819.93 (1.3% away, 0.47 ATR, 23 touches)
- Major: 812.04 (2.3% away, 0.81 ATR, 31 touches)
- Mid: 834.51 (0.4% away, 0.16 ATR, 18 touches)
- Major: 842.44 (1.4% away, 0.49 ATR, 23 touches)
- Major: 851.96 (2.5% away, 0.9 ATR, 25 touches)
Trends
Evidence
- Average earnings surprise
- +3.0%
- May 7, 2026: actual EPS 11.69 vs estimate 11.57 (surprise +1.1%)
- February 4, 2026: actual EPS 9.34 vs estimate 9.27 (surprise +0.7%)
- November 5, 2025: actual EPS 9.86 vs estimate 9.05 (surprise +8.9%)
- August 6, 2025: actual EPS 8.26 vs estimate 8.15 (surprise +1.4%)
Expected move
- Implied move
- +2.4%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 3.5%
- 75th percentile move
- 5.5%
- 90th percentile move
- 11.2%
- Up / down moves
- 11 / 9
- Average up move
- +5.5%
- Average down move
- -3.3%
Monitoring and close
What McKesson Corporation reported
- Status
- Finished
| Actual EPS | 9.93 |
|---|---|
| EPS estimate | 9.54 |
| EPS surprise | +4.1% |
| Revenue | $105,380 million |
| Revenue estimate | $103,738 million |
| Revenue surprise | +1.6% |
McKesson reported first-quarter results that topped estimates, with adjusted EPS of $9.93 versus $9.54 expected and revenue of $105.38 billion versus $103.74 billion. The company also raised its fiscal 2027 earnings guidance.
Sources (4)
- McKesson Raises FY2027 Adj EPS Guidance from $43.80-$44.60 to $44.20-$45.00 vs $44.26 Est; Sees Sales $423.601B-$439.739B vs $431.419B Est (opens in a new tab) — Benzinga
- McKesson beat expectations in Q1: adjusted EPS of $9.93 versus $9.54 estimated, and revenue of $105.380 billion versus $103.738 billion. — Benzinga
- McKesson Q1 Adj. EPS $9.93 Beats $9.54 Estimate, Sales $105.380B Beat $103.738B Estimate (opens in a new tab) — Benzinga
- Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy. (opens in a new tab) — Barrons.com
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, results beat expectations on both earnings and revenue, and the price is indicating +2.3% pre-market, a move in line with the stock's usual reaction (about 3%). The figures don't confirm the prior scenario: there was no prior directional scenario to check against.
How the stock reacted
- Consolidated
- -0.6%
- Max move
- -4.3%
No verdict: the outlook took no direction, so there is nothing to score as a hit or a miss.